E-ISSN 2149-388X | ISSN 2149-0430
 
2025, Vol: 11, Issue: 1
11 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Original Article 


Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder

Serkan Gunes.


Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is a common psychiatric condition that affects the daily functioning of children, adolescents, and adults. In this study, we aim to determine the efficacy and tolerability of medications that frequently use in the treatment of ADHD.
Materials and Methods: 204 primary school-age children with documented DSM-5 ADHD diagnosis were included. Clinical characteristics of the sample were obtained from the medical records and structured psychiatric interviews. Improvement and side effects were assessed with the Clinical Global Impression-Improvement Scale (CGI-I) and the adverse effect scale developed by the authors, respectively.
Results: Mean age of the patients was 8.32±1.15 and 67.1% of the patients were male. 33.3% of the patients were using modified-release methylphenidate, 35.3% were using osmotic-release methylphenidate, and 31.4% were using Atomoxetine. The CGI-I was significantly different between the three groups (p=0.012). There was no significance in terms of treatment compliance. Sleep disturbances, appetite, and sadness were different between the groups.
Conclusion: Atomoxetine seems to be less effective and has fewer side effects than modified-release methylphenidate and osmotic-release methylphenidate. Modified release methylphenidate and osmotic-release methylphenidate appear to show similar effectiveness. Osmotic release methylphenidate may be associated with more and severe side effects.

Key words: ADHD, methylphenidate, atomoxetine, efficacy, tolerability


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Serkan Gunes
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Serkan Gunes. Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. Ulutas Med J. 2019; 5(1): 71-76. doi:10.5455/umj.20191130053404

Web Style

Serkan Gunes. Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. https://www.ulutasmedicaljournal.com/?mno=19648 [Access: March 15, 2025]. doi:10.5455/umj.20191130053404

AMA (American Medical Association) Style

Serkan Gunes. Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. Ulutas Med J. 2019; 5(1): 71-76. doi:10.5455/umj.20191130053404


Vancouver/ICMJE Style

Serkan Gunes. Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. Ulutas Med J. (2019), [cited March 15, 2025]; 5(1): 71-76. doi:10.5455/umj.20191130053404


Harvard Style

Serkan Gunes (2019) Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. Ulutas Med J, 5 (1), 71-76. doi:10.5455/umj.20191130053404


Turabian Style

Serkan Gunes. 2019. Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. THE ULUTAS MEDICAL JOURNAL, 5 (1), 71-76. doi:10.5455/umj.20191130053404


Chicago Style

Serkan Gunes. "Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder." THE ULUTAS MEDICAL JOURNAL 5 (2019), 71-76. doi:10.5455/umj.20191130053404


MLA (The Modern Language Association) Style

Serkan Gunes. "Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder." THE ULUTAS MEDICAL JOURNAL 5.1 (2019), 71-76. Print. doi:10.5455/umj.20191130053404


APA (American Psychological Association) Style

Serkan Gunes (2019) Comparison of Efficacy and Tolerability of Modified Release Methylphenidate, Osmotic-Release Methylphenidate and Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. THE ULUTAS MEDICAL JOURNAL, 5 (1), 71-76. doi:10.5455/umj.20191130053404


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writing a research pap ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.